{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:03:07Z","timestamp":1791925387705,"version":"4.3.4"},"publisher-location":"Cham","reference-count":48,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030504939","type":"print"},{"value":"9783030504946","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/164_2019_210","type":"book-chapter","created":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T08:03:32Z","timestamp":1554797012000},"page":"325-337","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Clinical Pharmacology and Pharmacometrics to Better Understand Physiological Changes During Pregnancy and Neonatal Life"],"prefix":"10.1007","author":[{"given":"Tamara","family":"van Donge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Evers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"van den Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Pfister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,10]]},"reference":[{"key":"210_CR1","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s40262-017-0618-1","volume":"57","author":"K Abduljalil","year":"2018","unstructured":"Abduljalil K, Johnson TN, Rostami-Hodjegan A (2018) Fetal physiologically-based pharmacokinetic models: systems information on fetal biometry and gross composition. Clin Pharmacokinet 57:1149\u20131171","journal-title":"Clin Pharmacokinet"},{"key":"210_CR2","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/bcp.12430","volume":"80","author":"K Allegaert","year":"2015","unstructured":"Allegaert K, Anker JN (2015) Adverse drug reactions in neonates and infants: a population-tailored approach is needed. Br J Clin Pharmacol 80:788\u2013795","journal-title":"Br J Clin Pharmacol"},{"key":"210_CR3","doi-asserted-by":"publisher","first-page":"989","DOI":"10.2165\/00003088-200544100-00001","volume":"44","author":"GD Anderson","year":"2005","unstructured":"Anderson GD (2005) Pregnancy-induced changes in pharmacokinetics. Clin Pharmacokinet 44:989\u20131008","journal-title":"Clin Pharmacokinet"},{"key":"210_CR4","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.3109\/14767058.2014.972926","volume":"28","author":"B Artunc-Ulkumen","year":"2015","unstructured":"Artunc-Ulkumen B, Guvenc Y, Goker A, Gozukara C (2015) Relationship of neutrophil gelatinase-associated lipocalin (NGAL) and procalcitonin levels with the presence and severity of the preeclampsia. J Matern Fetal Neonatal Med 28:1895\u20131900. \nhttps:\/\/doi.org\/10.3109\/14767058.2014.972926","journal-title":"J Matern Fetal Neonatal Med"},{"key":"210_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/bdd.1937","volume":"36","author":"JJ Bonner","year":"2015","unstructured":"Bonner JJ, Vajjah P, Abduljalil K, Jamei M, Rostami-Hodjegan A, Tucker GT, Johnson TN (2015) Does age affect gastric emptying time? A model-based meta-analysis of data from premature neonates through to adults. Biopharm Drug Dispos 36:245\u2013257","journal-title":"Biopharm Drug Dispos"},{"key":"210_CR6","first-page":"w14572","volume":"147","author":"C Bornhauser","year":"2017","unstructured":"Bornhauser C, Quack KL, Seifert B, Sim\u00f5es-W\u00fcst AP (2017) Diet, medication use and drug intake during pregnancy: data from the consecutive Swiss Health Surveys of 2007 and 2012. Swiss Med Wkly 147:w14572","journal-title":"Swiss Med Wkly"},{"key":"210_CR7","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s40262-015-0325-8","volume":"55","author":"A Colbers","year":"2016","unstructured":"Colbers A, Greupink R, Litjens C, Burger D, Russel FG (2016) Physiologically based modelling of darunavir\/ritonavir pharmacokinetics during pregnancy. Clin Pharmacokinet 55:381\u2013396","journal-title":"Clin Pharmacokinet"},{"key":"210_CR8","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1002\/cpt.1084","volume":"104","author":"A Dallmann","year":"2018","unstructured":"Dallmann A, Pfister M, van den Anker J, Eissing T (2018a) Physiologically based pharmacokinetic modeling in pregnancy: a systematic review of published models. Clin Pharmacol Ther 104:1110\u20131124","journal-title":"Clin Pharmacol Ther"},{"key":"210_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/jcph.1294","volume":"59","author":"A Dallmann","year":"2018","unstructured":"Dallmann A, van den Anker J, Pfister M, Koch G (2018b) Characterization of maternal and neonatal pharmacokinetic behavior of ceftazidime. J Clin Pharmacol 59:74\u201382","journal-title":"J Clin Pharmacol"},{"key":"210_CR10","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev-pharmtox-011613-135930","volume":"54","author":"F Etwel","year":"2014","unstructured":"Etwel F, Hutson JR, Madadi P, Gareri J, Koren G (2014) Fetal and perinatal exposure to drugs and chemicals: novel biomarkers of risk. Annu Rev Pharmacol Toxicol 54:295\u2013315","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"210_CR11","first-page":"10314","volume":"117","author":"KS Evers","year":"2018","unstructured":"Evers KS et al (2018) Neurofilament as neuronal injury blood marker in preeclampsia. Hypertension 117:10314","journal-title":"Hypertension"},{"key":"210_CR12","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s10928-016-9492-y","volume":"43","author":"C Hartmanshenn","year":"2016","unstructured":"Hartmanshenn C, Scherholz M, Androulakis IP (2016) Physiologically-based pharmacokinetic models: approaches for enabling personalized medicine. J Pharmacokinet Pharmacodyn 43:481\u2013504. \nhttps:\/\/doi.org\/10.1007\/s10928-016-9492-y","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"210_CR13","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.pharmthera.2008.02.005","volume":"118","author":"RN Hines","year":"2008","unstructured":"Hines RN (2008) The ontogeny of drug metabolism enzymes and implications for adverse drug events. Pharmacol Ther 118:250\u2013267","journal-title":"Pharmacol Ther"},{"key":"210_CR14","doi-asserted-by":"publisher","unstructured":"Huppertz B (2018) An updated view on the origin and use of angiogenic biomarkers for preeclampsia. Expert Rev Mol Diagn:1\u20139. \nhttps:\/\/doi.org\/10.1080\/14737159.2018.1546579","DOI":"10.1080\/14737159.2018.1546579"},{"key":"210_CR15","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1161\/HYPERTENSIONAHA.116.06421","volume":"67","author":"SA Karumanchi","year":"2016","unstructured":"Karumanchi SA (2016) Angiogenic factors in preeclampsia: from diagnosis to therapy. Hypertension 67:1072\u20131079. \nhttps:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.116.06421","journal-title":"Hypertension"},{"key":"210_CR16","first-page":"83","volume-title":"Seminars in fetal and neonatal medicine","author":"JT Kastl","year":"2017","unstructured":"Kastl JT (2017) Renal function in the fetus and neonate\u2013the creatinine enigma. In: Seminars in fetal and neonatal medicine, vol 2. Elsevier, Amsterdam, pp 83\u201389"},{"key":"210_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/psp4.12274","volume":"7","author":"AB Ke","year":"2018","unstructured":"Ke AB, Greupink R, Abduljalil K (2018) Drug dosing in pregnant women: challenges and opportunities in using physiologically based pharmacokinetic modeling and simulations. CPT Pharmacometrics Syst Pharmacol 7:103\u2013110","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"210_CR18","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1056\/NEJMra035092","volume":"349","author":"GL Kearns","year":"2003","unstructured":"Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE (2003) Developmental pharmacology\u2014drug disposition, action, and therapy in infants and children. N Engl J Med 349:1157\u20131167","journal-title":"N Engl J Med"},{"key":"210_CR19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S1473-3099(10)70288-7","volume":"11","author":"Kesho Bora Study Group","year":"2011","unstructured":"Kesho Bora Study Group (2011) Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial. Lancet Infect Dis 11:171\u2013180","journal-title":"Lancet Infect Dis"},{"key":"210_CR20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jpeds.2017.08.064","volume":"191","author":"G Koch","year":"2017","unstructured":"Koch G, Datta AN, Jost K, Schulzke SM, van den Anker J, Pfister M (2017) Caffeine citrate dosing adjustments to assure stable caffeine concentrations in preterm neonates. J Pediatr 191:50\u201356.e51","journal-title":"J Pediatr"},{"key":"210_CR21","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1093\/clinchem\/43.1.222","volume":"43","author":"G Koren","year":"1997","unstructured":"Koren G (1997) Therapeutic drug monitoring principles in the neonate. Clin Chem 43:222\u2013227","journal-title":"Clin Chem"},{"key":"210_CR22","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/sj.clpt.6100506","volume":"83","author":"G Koren","year":"2008","unstructured":"Koren G, Hutson J, Gareri J (2008) Novel methods for the detection of drug and alcohol exposure during pregnancy: implications for maternal and child health. Clin Pharmacol Ther 83:631\u2013634","journal-title":"Clin Pharmacol Ther"},{"key":"210_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/pr.2014.143","volume":"77","author":"LC Ku","year":"2014","unstructured":"Ku LC, Smith PB (2014) Dosing in neonates: special considerations in physiology and trial design. Pediatr Res 77:2","journal-title":"Pediatr Res"},{"key":"210_CR24","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/10641955.2018.1524478","volume":"37","author":"K Kumer","year":"2018","unstructured":"Kumer K, Premru-Srsen T, Fabjan-Vodusek V, Tul N, Fabjan T, Osredkar J (2018) Peripheral arterial tonometry and angiogenic biomarkers in preeclampsia. Hypertens Pregnancy 37:197\u2013203. \nhttps:\/\/doi.org\/10.1080\/10641955.2018.1524478","journal-title":"Hypertens Pregnancy"},{"key":"210_CR25","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1056\/NEJMoa031884","volume":"350","author":"RJ Levine","year":"2004","unstructured":"Levine RJ et al (2004) Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350:672\u2013683. \nhttps:\/\/doi.org\/10.1056\/NEJMoa031884","journal-title":"N Engl J Med"},{"key":"210_CR26","doi-asserted-by":"publisher","first-page":"328","DOI":"10.2165\/00003088-199733050-00002","volume":"33","author":"R Loebstein","year":"1997","unstructured":"Loebstein R, Lalkin A, Koren G (1997) Pharmacokinetic changes during pregnancy and their clinical relevance. Clin Pharmacokinet 33:328\u2013343","journal-title":"Clin Pharmacokinet"},{"key":"210_CR27","doi-asserted-by":"publisher","first-page":"R237","DOI":"10.1093\/hmg\/ddx210","volume":"26","author":"I Manokhina","year":"2017","unstructured":"Manokhina I, Del Gobbo GF, Konwar C, Wilson SL, Robinson WP (2017) Review: placental biomarkers for assessing fetal health. Hum Mol Genet 26:R237\u2013R245","journal-title":"Hum Mol Genet"},{"key":"210_CR28","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1365-2125.2009.03484.x","volume":"68","author":"E Manolis","year":"2009","unstructured":"Manolis E, Pons G (2009) Proposals for model-based paediatric medicinal development within the current European Union regulatory framework. Br J Clin Pharmacol 68:493\u2013501","journal-title":"Br J Clin Pharmacol"},{"key":"210_CR29","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1602\/neurorx.1.2.182","volume":"1","author":"R Mayeux","year":"2004","unstructured":"Mayeux R (2004) Biomarkers: potential uses and limitations. NeuroRx 1:182\u2013188","journal-title":"NeuroRx"},{"key":"210_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.semnephrol.2010.10.004","volume":"31","author":"SE Maynard","year":"2011","unstructured":"Maynard SE, Karumanchi SA (2011) Angiogenic factors and preeclampsia. Semin Nephrol 31:33\u201346. \nhttps:\/\/doi.org\/10.1016\/j.semnephrol.2010.10.004","journal-title":"Semin Nephrol"},{"key":"210_CR31","doi-asserted-by":"publisher","first-page":"51. e51","DOI":"10.1016\/j.ajog.2011.02.029","volume":"205","author":"AA Mitchell","year":"2011","unstructured":"Mitchell AA, Gilboa SM, Werler MM, Kelley KE, Louik C, Hern\u00e1ndez-D\u00edaz S, Study NBDP (2011) Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. Am J Obstet Gynecol 205:51. e51\u201351. e58","journal-title":"Am J Obstet Gynecol"},{"key":"210_CR32","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1542\/peds.110.5.e53","volume":"110","author":"TJ Moore","year":"2002","unstructured":"Moore TJ, Weiss SR, Kaplan S, Blaisdell CJ (2002) Reported adverse drug events in infants and children under 2 years of age. Pediatrics 110:e53\u2013e53","journal-title":"Pediatrics"},{"key":"210_CR33","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.clp.2016.04.001","volume":"43","author":"SU Morton","year":"2016","unstructured":"Morton SU, Brodsky D (2016) Fetal physiology and the transition to extrauterine life. Clin Perinatol 43:395\u2013407","journal-title":"Clin Perinatol"},{"key":"210_CR34","doi-asserted-by":"publisher","first-page":"e1002160","DOI":"10.1371\/journal.pmed.1002160","volume":"13","author":"G Pariente","year":"2016","unstructured":"Pariente G, Leibson T, Carls A, Adams-Webber T, Ito S, Koren G (2016) Pregnancy-associated changes in pharmacokinetics: a systematic review. PLoS Med 13:e1002160","journal-title":"PLoS Med"},{"key":"210_CR35","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1080\/00365513.2017.1393692","volume":"77","author":"M Risch","year":"2017","unstructured":"Risch M et al (2017) High first-trimester maternal blood cystatin C levels despite normal serum creatinine predict pre-eclampsia in singleton pregnancies. Scand J Clin Lab Invest 77:634\u2013643. \nhttps:\/\/doi.org\/10.1080\/00365513.2017.1393692","journal-title":"Scand J Clin Lab Invest"},{"key":"210_CR36","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1055\/s-0033-1361831","volume":"31","author":"M Saint-Faust","year":"2014","unstructured":"Saint-Faust M, Boubred F, Simeoni U (2014) Renal development and neonatal adaptation. Am J Perinatol 31:773\u2013780","journal-title":"Am J Perinatol"},{"key":"210_CR37","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s40262-017-0583-8","volume":"57","author":"S Schalkwijk","year":"2018","unstructured":"Schalkwijk S, Buaben AO, Freriksen JJ, Colbers AP, Burger DM, Greupink R, Russel FG (2018) Prediction of fetal darunavir exposure by integrating human ex-vivo placental transfer and physiologically based pharmacokinetic modeling. Clin Pharmacokinet 57:705\u2013716","journal-title":"Clin Pharmacokinet"},{"key":"210_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-642-20195-0_1","volume-title":"Pediatric clinical pharmacology","author":"HW Seyberth","year":"2011","unstructured":"Seyberth HW, Kauffman RE (2011) Basics and dynamics of neonatal and pediatric pharmacology. In: Pediatric clinical pharmacology. Springer, Berlin, pp 3\u201349"},{"key":"210_CR39","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0140-6736(10)60279-6","volume":"376","author":"EA Steegers","year":"2010","unstructured":"Steegers EA, Von Dadelszen P, Duvekot JJ, Pijnenborg R (2010) Pre-eclampsia. Lancet 376:631\u2013644","journal-title":"Lancet"},{"key":"210_CR40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.psyneuen.2014.12.009","volume":"53","author":"SA Stout","year":"2015","unstructured":"Stout SA, Espel EV, Sandman CA, Glynn LM, Davis EP (2015) Fetal programming of children\u2019s obesity risk. Psychoneuroendocrinology 53:29\u201339","journal-title":"Psychoneuroendocrinology"},{"key":"210_CR41","first-page":"195","volume-title":"Seminars in pediatric surgery","author":"M Sulemanji","year":"2013","unstructured":"Sulemanji M, Vakili K (2013) Neonatal renal physiology. In: Seminars in pediatric surgery, vol 4. Elsevier, Amsterdam, pp 195\u2013198"},{"key":"210_CR42","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1002\/jcph.1284","volume":"58","author":"J van den Anker","year":"2018","unstructured":"van den Anker J, Reed MD, Allegaert K, Kearns GL (2018) Developmental changes in pharmacokinetics and pharmacodynamics. J Clin Pharmacol 58:S10\u2013S25","journal-title":"J Clin Pharmacol"},{"key":"210_CR43","doi-asserted-by":"crossref","first-page":"02004","DOI":"10.1128\/AAC.02004-17","volume":"62","author":"T van Donge","year":"2018","unstructured":"van Donge T, Pfister M, Bielicki J, Csajka C, Rodieux F, van den Anker J, Fuchs A (2018) Quantitative analysis of gentamicin exposure in neonates and infants calls into question its current dosing recommendations. Antimicrob Agents Chemother 62:02004\u201302017","journal-title":"Antimicrob Agents Chemother"},{"key":"210_CR44","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nm1429","volume":"12","author":"S Venkatesha","year":"2006","unstructured":"Venkatesha S et al (2006) Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12:642\u2013649. \nhttps:\/\/doi.org\/10.1038\/nm1429","journal-title":"Nat Med"},{"key":"210_CR45","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.preghy.2015.09.004","volume":"5","author":"M Widmer","year":"2015","unstructured":"Widmer M et al (2015) Accuracy of angiogenic biomarkers at \u226420 weeks\u2019 gestation in predicting the risk of pre-eclampsia: a WHO multicentre study. Pregnancy Hypertens 5:330\u2013338","journal-title":"Pregnancy Hypertens"},{"key":"210_CR46","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jpeds.2016.02.044","volume":"173","author":"M Wilbaux","year":"2016","unstructured":"Wilbaux M, Kasser S, Wellmann S, Lapaire O, Van Den Anker JN, Pfister M (2016) Characterizing and forecasting individual weight changes in term neonates. J Pediatr 173:101\u2013107. e110","journal-title":"J Pediatr"},{"key":"210_CR47","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1124\/dmd.116.073957","volume":"45","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Unadkat JD (2017) Development of a novel maternal-fetal physiologically based pharmacokinetic model II: verification of the model for passive placental permeability drugs. Drug Metab Dispos 45:939\u2013946","journal-title":"Drug Metab Dispos"},{"key":"210_CR48","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1124\/dmd.117.075192","volume":"45","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Imperial MZ, Patilea-Vrana GI, Wedagedera J, Gaohua L, Unadkat JD (2017) Development of a novel maternal-fetal physiologically based pharmacokinetic model I: insights into factors that determine fetal drug exposure through simulations and sensitivity analyses. Drug Metab Dispos 45:920\u2013938","journal-title":"Drug Metab Dispos"}],"container-title":["Handbook of Experimental Pharmacology","Pediatric Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2019_210","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T13:07:08Z","timestamp":1594818428000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/164_2019_210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030504939","9783030504946"],"references-count":48,"URL":"https:\/\/doi.org\/10.1007\/164_2019_210","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"10 April 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}